Article Menu
Need Help?
No Article Versions Notes Found
Cite
Bennett, S.; Søreide, K.; Gholami, S.; Pessaux, P.; Teh, C.; Segelov, E.; Kennecke, H.; Prenen, H.; Myrehaug, S.; Callegaro, D.; et al. Strategies for the Delay of Surgery in the Management of Resectable Hepatobiliary Malignancies during the COVID-19 Pandemic. Curr. Oncol. 2020, 27, 501-511. https://doi.org/10.3747/co.27.6785
Bennett S, Søreide K, Gholami S, Pessaux P, Teh C, Segelov E, Kennecke H, Prenen H, Myrehaug S, Callegaro D, et al. Strategies for the Delay of Surgery in the Management of Resectable Hepatobiliary Malignancies during the COVID-19 Pandemic. Current Oncology. 2020; 27(5):501-511. https://doi.org/10.3747/co.27.6785
Chicago/Turabian StyleBennett, S., K. Søreide, S. Gholami, P. Pessaux, C. Teh, E. Segelov, H. Kennecke, H. Prenen, S. Myrehaug, D. Callegaro, and et al. 2020. "Strategies for the Delay of Surgery in the Management of Resectable Hepatobiliary Malignancies during the COVID-19 Pandemic" Current Oncology 27, no. 5: 501-511. https://doi.org/10.3747/co.27.6785
APA StyleBennett, S., Søreide, K., Gholami, S., Pessaux, P., Teh, C., Segelov, E., Kennecke, H., Prenen, H., Myrehaug, S., Callegaro, D., & Hallet, J. (2020). Strategies for the Delay of Surgery in the Management of Resectable Hepatobiliary Malignancies during the COVID-19 Pandemic. Current Oncology, 27(5), 501-511. https://doi.org/10.3747/co.27.6785
